Keywords: zambon, sheffield, begin, trials, ipratropium, msi, medarex

Zambon and Sheffield begin trials of ipratropium in MSI

Article | 05 January 2000

Print This

Medarex says that in a preclinical study of MDX-44, a monoclonalantibody product for use in certain skin disorders and inflammatory ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in